BB BIOTECH AG

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Signature - Title
Martin Gubler / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen, Switzerland
Summary
This page shows a list of all the recent 13F filings made by BB BIOTECH AG. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BB BIOTECH AG didn't report any stock holdings as of Q3 2024. Bellevue Group AG is reporting for BB BIOTECH AG.
Holdings Value

Bellevue Group AG is reporting for BB BIOTECH AG:

Name Holdings Value Location File Number
Bellevue Group AG $6.17B Kuesnacht, Switzerland 028-17462
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 13F-NT 11/14/2024, 05:23 PM
Q2 2024 13F-NT 8/14/2024, 02:11 PM
Q1 2024 13F-NT 5/15/2024, 03:07 PM
Q4 2023 13F-NT 2/14/2024, 12:17 PM
Q3 2023 0 13F-NT 11/14/2023, 01:59 PM
Q2 2023 0 13F-NT 8/14/2023, 12:58 PM
Q1 2023 0 13F-NT 5/15/2023, 10:31 AM
Q4 2022 0 13F-NT 2/14/2023, 11:51 AM
Q3 2022 0 13F-NT 11/14/2022, 01:01 PM
Q2 2022 0 13F-NT 8/11/2022, 11:01 AM
Q1 2022 0 13F-NT 5/13/2022, 04:24 PM
Q4 2021 0 13F-NT 2/10/2022, 09:57 AM
Q3 2021 0 13F-NT 11/12/2021, 05:35 AM
Q2 2021 0 13F-NT 8/12/2021, 12:54 PM
Q1 2021 0 13F-NT 5/11/2021, 05:49 PM
Q4 2020 0 13F-NT 2/16/2021, 08:10 AM
Q3 2020 0 13F-NT 11/16/2020, 03:25 PM
Q2 2020 0 13F-NT 8/13/2020, 04:07 PM
Q1 2020 0 13F-NT 5/14/2020, 02:26 PM
Q4 2019 0 13F-NT 2/14/2020, 01:33 PM
Q3 2019 0 13F-NT 11/14/2019, 03:58 PM
Q2 2019 0 13F-NT 8/14/2019, 02:29 PM
Q1 2019 35 $3.98B +$159M -$160M -$512K IONS, INCY, NBIX, VRTX, SAGE 13F-HR 5/13/2019, 12:49 PM
Q4 2018 34 $3.12B +$322M -$251M +$70.8M IONS, INCY, NBIX, VRTX, ESPR 13F-HR 2/12/2019, 05:21 PM
Q3 2018 32 $3.78B +$164M -$140M +$24M IONS, NBIX, CELG, VRTX, INCY 13F-HR 11/9/2018, 04:57 PM
Q2 2018 32 $3.46B +$225M -$149M +$75.4M IONS, NBIX, CELG, INCY, VRTX 13F-HR 8/9/2018, 04:17 PM
Q1 2018 30 $3.62B +$169M -$135M +$34M IONS, INCY, CELG, NBIX, VRTX 13F-HR 5/8/2018, 05:23 PM
Q4 2017 30 $3.55B +$159M -$26.4M +$132M IONS, CELG, INCY, NBIX, VRTX 13F-HR 2/14/2018, 03:39 PM
Q3 2017 27 $3.61B +$159M -$103M +$56.8M CELG, INCY, IONS, GILD, VRTX 13F-HR 11/13/2017, 11:56 AM
Q2 2017 28 $3.27B +$90.4M -$82.1M +$8.33M INCY, CELG, IONS, RDUS, GILD 13F-HR 8/11/2017, 01:46 PM
Q1 2017 30 $3.06B +$92M -$99.9M -$7.88M INCY, CELG, IONS, GILD, RDUS 13F-HR 5/10/2017, 12:34 PM
Q4 2016 29 $2.7B +$80.6M -$66.8M +$13.8M CELG, INCY, IONS, GILD, RDUS 13F-HR 2/14/2017, 02:10 PM
Q3 2016 29 $2.84B +$107M -$172M -$65.1M INCY, CELG, IONS, RDUS, GILD 13F-HR 11/10/2016, 04:17 PM
Q2 2016 30 $2.53B +$89.3M -$66.3M +$23M CELG, INCY, GILD, IONS, RDUS 13F-HR 8/12/2016, 04:55 PM
Q1 2016 29 $2.52B +$37.8M -$4.45M +$33.4M CELG, INCY, IONS, GILD, ALXN 13F-HR 5/12/2016, 05:12 PM
Q4 2015 30 $3.55B +$475M -$292M +$182M CELG, INCY, IONS, GILD, RDUS 13F-HR 2/9/2016, 05:02 PM
Q3 2015 28 $3.15B +$323M -$139M +$183M INCY, CELG, RDUS, GILD, ISIS 13F-HR 11/12/2015, 08:48 AM
Q2 2015 29 $3.69B +$230M -$168M +$61.5M CELG, INCY, ISIS, GILD, RDUS 13F-HR 8/12/2015, 12:03 PM
Q1 2015 27 $3.36B +$138M -$202M -$63.8M CELG, ISIS, INCY, GILD, AGIO 13F-HR 5/14/2015, 03:12 PM
Q4 2014 28 $3.09B +$176M -$121M +$55.2M CELG, ISIS, INCY, GILD, AGIO 13F-HR 2/12/2015, 05:27 PM
Q3 2014 26 $2.46B +$205M -$163M +$42M CELG, GILD, ISIS, INCY, VRTX 13F-HR 11/13/2014, 04:53 PM
Q2 2014 24 $2.1B +$317M -$15.3M +$301M CELG, GILD, INCY, ISIS, VRTX 13F-HR 8/7/2014, 03:43 PM
Q1 2014 24 $1.94B +$71.2M -$32.9M +$38.3M CELG, ISIS, GILD, INCY, ALXN 13F-HR 5/8/2014, 04:51 PM
Q4 2013 23 $1.87B $0 $0 CELG, GILD, ISIS, INCY, VRTX 13F-HR 2/12/2014, 12:36 PM